A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Fecal Bacteroidetes: Firmicutes Ratio in Pre-Diabetic Subjects

Trial Profile

A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Fecal Bacteroidetes: Firmicutes Ratio in Pre-Diabetic Subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Aug 2014

At a glance

  • Drugs NM 504 (Primary)
  • Indications Prediabetic-state
  • Focus Pharmacodynamics
  • Acronyms PrCo
  • Sponsors MicroBiome Therapeutics
  • Most Recent Events

    • 23 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Feb 2014 Positive top-line results published in a MicroBiome Therapeutics media release.
    • 16 Dec 2013 MicroBiome Therapeutics completed bridge financing intended to support completion of this trial, according to a company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top